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Abstract
Lymph node staging is of crucial importance for the 
therapy stratification and prognosis estimation in 
colon cancer. Beside the detection of metastases, the 
number of harvested lymph nodes itself has prognostic 
relevance in stage Ⅱ/Ⅲ cancers. A stage migration 
effect caused by missed lymph node metastases has 
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been postulated as most likely explanation for that. In 
order to avoid false negative node staging reporting 
of at least 12 lymph nodes is recommended. However, 
this threshold is met only in a minority of cases in daily 
practice. Due to quality initiatives the situation has 
improved in the past. This, however, had no influence 
on staging in several studies. While the numbers of 
evaluated lymph nodes increased continuously during 
the last decades the rate of node positive cases 
remained relatively constant. This fact together with 
other indications raised doubts that understaging is 
indeed the correct explanation for the prognostic impact 
of lymph node harvest. Several authors assume that 
immune response could play a major role in this context 
influencing both the lymph node detectability and the 
tumor’s behavior. Further studies addressing this issue 
are need. Based on the findings the recommendations 
concerning minimal lymph node numbers and adjuvant 
chemotherapy should be reconsidered.
Key words: Colon cancer; Lymph node harvest; 
Stage migration; Understaging; Will Rogers; Immune 
response
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Core tip: The number of evaluated lymph nodes 
is prognostic in stage Ⅱ and Ⅲ colon cancers. 
Understaging due to inadequate lymph node harvest 
causing a stage migration effect is a widely accepted 
explanation for this. However, there is growing evidence 
that understaging plays only a minor role in this context. 
It seems much more likely that immune response 
has influence on the lymph nodes’ detectability and is 
associated with outcome in colon cancer.
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INTRODUCTION
Lymph node staging is still of crucial importance for 
the prognosis and the therapy stratification in colon 
cancer. The occurrence of lymph node metastases 
is associated with an adverse clinical course with an 
indication for adjuvant chemotherapy. In contrast, 
patients with stage Ⅰ/Ⅱ colon cancers show a 
considerable better outcome with a high rate of long-
term survivors. Because only a small number of 
these patients benefit from adjuvant chemotherapy 
it is restricted to high risk situations like T4-stage 
or emergency resections[1,2]. In order to ensure 
high quality in staging colon cancer several national 
guidelines recommend the histopathological evaluation 
of at least 12 lymph nodes[3,4]. On the other hand it 
is well known that this recommendation is achieved 
only partially sometimes only in a minority of cases[5,6]. 
Low lymph node yields, however, are associated with 
an adverse outcome[7]. Cases with low lymph node 
harvests might be prone to the missing of positive 
lymph nodes and understaging. In contrast, high 
numbers of evaluated lymph nodes could prevent from 
understaging. Actually, high numbers of investigated 
lymph nodes are associated with favorable outcome in 
colon cancer. A stage migration effect also called Will 
Rogers phenomenon introduced by Feinstein et al[8] 
would take place resulting in improved survival curves 
both for stage Ⅱ and Ⅲ cancers. The elimination 
of false node negative cases within the collective of 
stage Ⅰ/Ⅱ cases and the shift of relatively early nodal 
positive cases into the correct stage Ⅲ category is 
believed to cause such a phenomenon.
This prognostic impact of high lymph node yields 
prompted the demand of more intensive lymph 
node evaluations with up to 30 lymph nodes or even 
more[9-11]. Because insufficient lymph node harvest 
has been identified as an adverse prognostic factor 
adjuvant chemotherapy is recommended for patients 
with less than 12 identified lymph nodes regardless of 
the nodal status[1,2]. 
However, the achievement of the 12 lymph node 
threshold is not only of prognostic and therapeutic 
relevance. It has also implications in terms of the 
quality measurement in surgical oncology. It is widely 
accepted that the identification of at least 12 lymph 
nodes is a good surrogate marker for an adequately 
performed surgical resection[12]. This is still the 
case today although it could be shown by several 
investigation that the number of elevated lymph nodes 
is not only influenced by the surgeon but by many 
other very different factors including the pathologist, 
the age of the patient and the molecular alterations 
of the tumor[13,14]. The attempt to improve the quality 
of colon cancer therapy is very likely the reason for 
the increased rate of sufficiently staged cases in the 
past[9,15]. This development to an improved lymph 
node staging should influence the outcome statistics 
not only mathematically but also effectively because 
of a higher rate of correct stage adapted therapy. This 
would be a strong argument that understaging of 
cases with a poor lymph node yield is the reason for its 
prognostic impact. However, several authors express 
doubts that the Will Rogers phenomenon is really the 
correct explanation for this effect[16,17]. An alternative 
thesis is that immune response plays a major role 
in this context[16,18,19]. A strong immunologic reaction 
against the tumor could result in local lymph node 
hyperplasia with enlargement and enhanced lymph 
node detectability.
This review discusses the current literature in order 
to elucidate the biological nature of the prognostic 
impact of lymph node count in colon cancer.
For that a broad literature research within the 
MEDLINE Database was performed. The search terms 
included “lymph node” in combination with “colon” 
or “colorectal”. Additionally previously published 
reviews[7,20,21] were screened for relevant references 
that might have been missed by the initial MEDLINE 
search. Because this review emphasizes on colon 
cancer articles that solely deal with rectal cancers were 
excluded. Articles in English and German language 
were considered for integration. In order to answer the 
question of this review articles providing information 
about the following topics were of particular interest: 
Factors influencing the lymph node harvest; Prognostic 
impact of lymph node harvest; Lymph node positivity 
rates; Upstaging from N0 to N+ after secondary 
lymph node dissection; Effect of advanced dissection 
techniques; Effect of improved lymph node recovery 
over time; Comparison of differently performing 
hospitals; Indications for the role of immune response.
FACTORS INFLUENCING THE LYMPH 
NODE HARVEST
Analyzing the literature an increasing interest in 
identifying factors that influence the lymph node 
harvest is recognizable. It seems that a search is 
ongoing for the one who is to blame when the 12 
lymph nodes rule could not be achieved and for answer 
of the question whether it is justified to demand this 
rule in all situations. Forty-four studies investigating 
such potential factors, published between 2003 and 
2014, are included in this review. Before discussing 
these factors it might be worth to consider how 
many lymph nodes can be expected within a colonic 
specimen. Two studies reporting the results of entire 
submission of mesenteric tissue (ESMT). Brown et al[22] 
found about 90 lymph nodes per colonic specimen on 
average while Kim et al[23] detected about 43 lymph 
Märkl B. Lymph node count in colon cancer
12219 November 21, 2015|Volume 21|Issue 43|WJG|www.wjgnet.com
nodes in colorectal cancers. Anecdotally, the authors 
group found 360 lymph nodes in one specimen of a 
total colectomy using methylene blue assisted lymph 
node dissection (unpublished case). It is clear that the 
vast majority of these nodes are very tiny and barely 
visible. Nevertheless, these reports indicate that the 
theoretically achievable numbers are by far above the 
12 recommended lymph nodes. The main different 
factor categories are given in Table 1 and discussed 
below.
Surgery
The resection of the complete lymphatic basin is an 
essential part of the oncological adequate surgical 
therapy of colon cancer. As mentioned before the total 
number of evaluated lymph nodes is a well-established 
but also controversial debated marker for the surgery’s 
quality. Many of the published studies show significant 
differences between individual surgeons and/or 
positive associations between, surgeon’s experience/
qualification and/or surgical volume and the number of 
harvested lymph nodes[13,24-30]. A few studies, however, 
found no influence of surgery related variables[31,32]. 
Open and laparoscopic technique were shown to be 
equal in terms of lymph node retrieval in two meta-
analyses[33,34].
Pathology
The independent influence of the pathologist on 
lymph node retrieval is also reported in several 
studies[13,25,27,29,30,35,36]. Interestingly, an inverse 
association between qualification or level of training 
and number of identified lymph nodes is reported. 
Kuijpers et al[37] reported better results of pathology 
assistants compared to pathologists and Bamboat et 
al[35] showed that residents in their first year of training 
are more successful in dissecting lymph nodes than 
there more experienced colleagues. To pathologists 
these results are probably less surprising as the might 
be to others. Dissecting lymph nodes of a surgical 
specimen is certainly one of the most unpopular task 
in pathology. Diligence and lack of time play a major 
role in this context. Pathology assistance and young 
residents may have more time and patience to do a 
better job.
The usage of special techniques like fat clearance, 
methylene blue technique or ESMT improves the lymph 
node yield effectively in comparison to the conventional 
manual technique[38]. The same two studies that 
did not find lymph node retrieval influenced by the 
surgeon also reported a lacking influence of pathology 
related factors on[31,32]. This, however, is probably more 
the result of homogenous performance levels of these 
specialties within these single centers.
Patient
Patient related factors are unmodifiable and therefore 
different from the former discussed points. Patient’s 
age is mentioned by many authors as an independent 
predictor for the lymph node count[19,28,39-47]. All these 
studies reported consistently an inverse association 
between higher age and lymph node harvest. To 
our knowledge there are no studies available that 
investigated the underlying reasons for that. One can 
speculate that surgical aggressiveness differ between 
different age groups. On the other hand increasing age 
could be accompanied by a diminishing immunologic 
response resulting in smaller lymph nodes. 
The role of patient’s gender is somewhat more 
controversial. Gender was identified only by a minority 
of studies as a lymph node yield influencing factor. 
Nevertheless, three of the four of these studies 
reported an association of female sex with higher 
lymph node count[19,41,48]. Only Horzic et al[49] found a 
higher lymph node count in males.
Whether the body mass index (BMI) plays a role 
or not remains unclear. There are studies that found 
a positive association between particular low BMI and 
lymph node harvest[31,50] others report an association 
between high BMI and poor harvest[13,32]. Explanations 
again are speculative and point in the same direction 
as in age. In several other studies, however, no effect 
was seen[25,51,52].
Tumor
Tumor associated factors are also unmodifiable. There 
is strong evidence from 15 studies[14,19,26,28,31,36,39,42-44,53-57] 
that right location of the tumor is associated with 
significant higher lymph node counts compared to 
left sided tumors. This might be related to anatomic 
differences between the different parts of the colon. A 
higher rate of microsatellite instability (MSI) positive 
cancers - which are mainly located in the right colon - 
could be another explanation at least in certain a part of 
cases.
Like location, T-stage and/or tumor size were 
found to be predictive for the lymph node yield in 
colon cancer very often[13,31,36,41-43,46,49,55,56,58-60]. The 
immunogenicity of advanced tumors seems to be 
higher compared to low stages inducing a stronger 
reaction in lymph nodes. A more aggressive surgical 
treatment in advanced diseases is also thinkable.
Several authors report a positive correlation 
between lymph node number and the detection of 
lymph node metastases[41,44,56,61]. Nevertheless, it 
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Table 1  Factors with influence on lymph node harvest in 
colorectal cancers
Surgery Pathology Patient Tumor Other
Experience Experience Age Location Specimen length
Volume Technique Gender T-stage Hospital status
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BMI: Body mass index; MSI: Microsatellite instability.
influencing[19,26,29,47,55,56,60].
A view studies investigated the impact of hospital 
status on lymph node count retrieval[60,66-68]. The 
results indicate that teaching and high volume centers 
are more successful in identifying a sufficient number 
of lymph nodes.
PROGNOSTIC RELEVANCE OF LYMPH 
NODE COUNT IN COLON CANCER
We identified 49 studies published between 1998 and 
2014 including total 625279 (range: 94-194459) that 
investigated the prognostic impact of lymph node 
count in colon and colorectal cancers, respectively. 
These studies show a very high heterogeneity in 
many respects. The study endpoint differ as cut offs, 
included locations and stages, case numbers and study 
designs do. Two nested cohort studies[69,70] and 10 
register studies[45,71-79] were found. The other studies 
are mainly performed in single centers.
Stage Ⅰ /Ⅱ  colon cancers
All seven studies that were restricted to stage Ⅰ/Ⅱ 
cancers colon cancers showed survival advantages with 
considerable risk reductions for the groups with higher 
lymph node counts (Table 2)[28,76,77,79-82] or increased risk 
for patients with low lymph node yields. Most authors 
used defined cut offs for their analyses. Swanson et 
al[77] however showed a linear increase of the 5 year 
overall survival rates with increasing numbers of 
evaluated lymph nodes (Figure 1). The work of Sato 
and coworkers[82] seems unique because of addressing 
the issue of adjuvant chemotherapy in patients with 
poor lymph node yield. The authors reported an 
improved outcome in the chemotherapy group. 
Stage Ⅰ -Ⅲ  colon cancers
Twelve studies performed between 2002 and 2014 
investigated colon cancers with and without lymph 
node metastases (stage Ⅰ-Ⅲ or stage Ⅲ colon cancers 
exclusively) (Table 3)[44,45,54,69-71,73,74,78,83-85]. Both nested 
cohort studies[69,70] which are retrospective analyzes 
from two large multicenter studies belong to this 
group. All ten studies that included stage Ⅱ cases 
seems questionable whether this means that a greater 
lymph node yield necessarily results in in higher 
detection of metastases. The opposite linkage - the 
metastatic involvement induce a stronger lymph node 
reaction - is at least as plausible similar to advanced 
T-stages.
Lymph node size was recently reported as being 
associated with total lymph node count by the authors 
group, Märkl et al[62] and Sloothaak et al[63]. MSI is 
also believed to interfere with the lymph node count. 
However, we found only four articles addressing 
this issue. Three authors report higher lymph node 
numbers in MSI positive cancers[14,53,64]. MacQuarrie et 
al[65] did not find such an association focusing on stage 
Ⅲ cancers. Both factors lymph nodes size and MSI 
might indicate an immunologic association.
Other factors
Other factors that influence lymph node yields are the 
specimen length, the status of the hospital and the 
year of diagnosis/operation. The latter will discussed in 
detail in one of the following paragraphs. The specimen 
length is probably multifactorial influenced by the 
surgeon, the tumor and patient’s individual anatomy. 
Several studies report this factor as lymph node count 
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Table 2  Prognostic relevance of lymph node harvest in stage Ⅱ colon cancers
First author Year n Insuff.-rate pT3/4 Prognostic Endpoints Cut off Survival
Swanson 2003 35787 60% 100% Yes 5yOS No cut off linear increase of 5yOS-rate
Law 2003       115 NA 100% Yes 5yOS, 5yDFS ≥ 7 5yOS: < 7LN 69% vs > 6LN 89%
Bui 2006        4531 NA NA Yes OS 1-3 vs 10-36 HR = 0.6 (CI: 0.4-1.0), P = 0.03
Bilimoria 2008 142009 NA   59% Yes 5yOS ≥ 12 HR = 0.75 (CI: 0.71-0.8), P < 0.0001
Maggard 2009   11263 NA   69% Yes 5yOS 4 (T1) and 10 (T2) T1: HR = 0.76 (CI: 0.641-0.902), P = 0.002 
T2: 0.853 (CI: 0.776-0.937), P = 0.001
Stocchi 2011       901 NA 100% Yes OS, DFS, CsS ≥ 12 < 12 LN: HR = 1.93 (1.27-2.94),  P = 0.002
Sato 2011     1476 56% 100% Yes 5yOS > 12 ACT: improved 5yOS for LNs ≤ 12
1Sub-group of the study collection. NA: No available data; 5yOS: 5 years overall survival; 5yDFS: 5 years disease-free survival; OS: Overall survival; CsS: 
Cancer specific survival; ACT: Adjuvant chemotherapy; LN: Lymph node.
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Figure 1  Linear correlation between between 5-year overall survival rates 
and lymph node count in T3N0 colon cancers calculated on the data 
published by Swanson et al[77].
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found favorable outcomes of the groups with higher 
lymph node counts. Again the chosen cut offs differed 
considerable. In 8 of 12 studies superior survival 
rates were found in stage Ⅲ cancers also. One study 
showed an advantage for cases with low lymph node 
ratio (number metastatic lymph node divided by total 
lymph node number). Three groups including Kelder et 
al[44], Prandi et al[70] and Tsikitis et al[85] however, found 
no significant association between lymph node harvest 
and outcome in stage Ⅲ cancers.
Stage Ⅰ /Ⅱ  colorectal cancers
Twelve publication between 2002 and 2013 were 
restricted to stage Ⅰ/Ⅱ cases but included both colon 
and rectal cancers (Table 4)[47,72,86-95]. Despite the very 
different cut off points and endpoints, all except one 
paper reported favorable outcomes for the groups 
with better lymph node harvests. Nir et al[91] were not 
able to show such an effect. This, however, might be 
the result of a relatively small sample number with 
only 117 cases. The authors reported at least a non-
significant trend (P = 0.15) towards better disease free 
survival in the group of ≥ 12 lymph nodes.
Stage Ⅰ -Ⅲ  colorectal cancers
Node negative and positive colorectal cancers were 
investigated in 17 studies between 1998 and 2014 
(Table 5)[19,26,75,96-109]. Again all but one study reported 
better clinical courses for cases with higher lymph 
node counts in stage Ⅱ cancers. The half of the 
studies, however, found no significant difference in 
stage Ⅲ cancers. An explanation for this discrepancy 
to the findings in other constellations could be that 
fact locally advanced rectal cancers are usually treated 
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Table 3  Prognostic relevance of lymph node harvest in stage Ⅱ and Ⅲ colon cancers




Prandi1 2002     3491    48%   501% n.m. OS, PFS 8-12 (RR = 0.46) vs 
13-17 (RR = 0.76) vs 
> 17 (RR = 0.79)
Yes No
Le Voyer2 2003     3411    81% NA    89% CsS N1: ≥ 12 vs > 10 vs > 40; 
N2: > 35; 
N0: ≥ 12 vs ≥ 12 vs > 20 
and < 35
Yes Yes
Jestin 2004     3735    31% NA NA OS ≥ 12 Yes /3
Johnson 2006   20702  100% NA    92% 5yCsS < 4 neg LN vs > 12 neg LN / Yes
Kelder 2009     2281 32.4%    79%    79% 5yOS < 6; 6-11; > 11 Yes N
Tsikitis 2009       329  100%    49% NA CsS/DFS > 12 / N
Vather 2009     4309 NA NA NA 5yOS 4 LN wide steps Yes Yes
Dillman 2009       574 NA NA NA OS ≥ 12 Yes No
Shanmugam 2011       490 46.9%    24% NA 5yCsS/CsS ≥ 20 Yes Yes
Chang 2012     9644    41% 27.7% 80.2% 5yOS ≥ 12 Yes Yes
Gleisner 2013 154208     34%4 NA 69.4% OS Linear risk reduction up to 25 
LN in N- and up 10 LN in N+
Yes Yes
Khan 2014 194459 NA    41% NA CsS ≥ 12 LN Yes Yes
1Intergroup Trial INT-0089; 2INTAC-Trail; 3Lymph node ratio is prognostic; 4Mean out of two collectives. NA: No available data; 5yOS: 5 year overall 
survival; 5yDFS: 5 year disease-free survival; OS: Overall survival; CsS: Cancer specific survival; HR: Hazard rate; ACT: Adjuvant chemotherapy; LN: 
Lymph node; PFS: Progression-free survival; DFS: Disease-free survival; N-: Node negative; N+: Node positive.
Table 4  Prognostic relevance of lymph node harvest in stage Ⅱ colorectal cancers
First author Year n Insuff rate pT3/4 Prognostic Endpoint Cut off Survival
Cserni 2002 8574 NA 100% Yes OS No cut off Continuously improved survival
Cianchi 2002   140 min 40%1 n.m. Yes 5yOS ≥ 9 54.9% vs 79.9%, P < 0.001
Wong 2002   345 NA NA ≥ 68 DFS 22.6 vs 11.32 40% vs 90%1, P < 0.001
Berberoglu 2004   301      53.5%1   69% Yes 5yOS ≤ 10 RR = 2.8 (CI: 1.6-5.2), P = 0.0008
Yoshimatsu 2005     94        35% 100% Yes 5yOS ≥ 9 66.7% vs 86.7%
Tsai 2007   180 NA   70% Yes OS ≥ 18 5yOS: 70 vs 98%1, P = 0.015
Norwood 2009 2449 NA NA Yes OS < 12 about 15% difference1, P = 0.001
Ishizuka 2010   205 min 36%1 100% Yes CsS ≤ 9 vs > 9 44.5 mo vs 66 mo, P = 0.0042
Nir 2010   117        28% 100% No 5yOS, 5yDFS ≥ 12 No difference
La Torre 2012   204        16% 100% Yes 5yDFS, 5yCsS, and 5yOS > 12 5yOS 78.5% vs 53.1%, P = 0.001
Iachetta 2013   657        22% 100% Yes CsS/PFS < 12 vs ≥ 20 HR = 0.49 (CI: 0.30-0.79), P = 0.003
Xingmao 2013   729 NA 100% Yes OS > 12 88.7% vs 64.9%, P = 0.000
1Estimated based on Kaplan-Meier-curve; 2Comparision of different cohorts. NA: No available data; 5yOS: 5 year overall survival; 5yDFS: 5 year disease-
free survival; OS: Overall survival; CsS: Cancer specific survival; HR: Hazard rate; LN: Lymph node; PFS: Progression-free survival.
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by neoadjuvant radiochemotherapy which itself is 
associated with decreased lymph node yields[13]. 
Govindarajan et al[110] found that lymph node harvests 
beyond the 12 lymph node rule in neoadjuvantly 
treated rectal cancers were not associated with 
understaging or inferior survival.
LYMPH NODE POSITIVITY RATES
For an estimation of the lymph node positivity rate 
that can be expected by conventional pathological 
examination technique 57 studies including about 
750000 cases of colon and colorectal cancers 
were analyzed published between 1987 and 2015 
[5,6,10,14,15,17,24,26,40-44,46,48,53,55,57,59,61,63,64,66,71,73,75,83,84,95,100,101,103-109,111-127]. 
The mean and median rates of lymph node positivity 
rate on the basis of the selected studies were 39% 
and 38% (range: 28-53) (Figure 2). Based on patients 
the mean percentage of node positive cases was 
37%. There was a significant correlation between the 
portion of pT3/4 cancers and the occurrence of lymph 
node metastases (Figure 3A). The rate of inadequately 
staged cancers, however, had no influence on the rate 
node positive cases (Figure 3B). The results of the five 
largest studies are given in Table 6. 
UPSTAGING AFTER RE-EVALUATION 
AND INFLUENCE OF ADVANCED 
TECHNIQUES
Influence of re-evaluation on staging
Fourteen studies were identified that evaluated the 
effect of secondary or even tertiary lymph node 
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Table 5  Prognostic relevance of lymph node harvest in stage Ⅱ and Ⅲ colorectal cancers
First author Year n N+ Insuff-rate pT3/4 Endpoints Cut off Stage Ⅱ Stage Ⅲ
Caplin 1998     377 NA NA NA OS > 6 Yes No
Sarli 2005   1040 NA NA  100% 5yOS < 10 Yes No
Wong 2005     21491    37% NA    67% OS > 13 Yes 1
George 2006   3592 NA    79% NA 5yOS 0-4; 5-10; > 10 Yes Yes
Edler 2007     125    51%    87% NA OS 0-11 vs > 11 Yes Yes1
Evans 2008     381 45.3%     47%1    82% 5yOS ≥ 9 Yes 2
Choi 2010     664 NA NA  100% DFS > 20 Yes No
Desolneux 2010     362 NA NA 72.4% OS < 8 vs ≥ 8 and < 12 vs ≥ 12 Yes No
Ogino 2010     716    38%     63%1 68.3% CsS/OS 0-3 negative LN, 7-12 and > or = 
13 negative LN
Yes Yes
Fretwell 2010     351    48% min 20%    95% 5yOS ≥ 9 (Dukes B); > 9 (Dukes C) Yes Yes
Wong 2011   8521 About 30%    32%    66% CsS medians: 4 vs 8 vs 10 Yes No
Kotake 2011 16865    46%     24%1  100% 5yOS < 10 vs > 27 Yes Yes
Kritsanasakul 2012     533    43% 59.1%    82% 5yOS ≥ 12 Yes 1
Moro-Valdezate 2013    11662 39.7%     65%1 79.7% 5yOS/5yCsS ≥ 12 No No
Zhang 2013     265 42.3% 75.1% 79.2% OS < 12 Yes Yes
Onitilo 2013   1397    37%    26%    67% OS ≥ 12 Yes Yes
Duraker 2014     461 NA    51%    74% CsS ≥ 12 Yes No1
1Survival analysis only in the nodal negative sub group (n = 1348); 2Based on cases with available survival data (n = 359). NA: No available data; 5yOS: 
5 year overall survival; 5yDFS: 5 year disease-free survival; OS: Overall survival; CsS: Cancer specific survival; HR: Hazard rate; LN: Lymph node; PFS: 
Progression-free survival. 
20      22     24      26      28      30      32     34      36      38     40      42      44     46      48      50      52     54
















Figure 2  Mean or median lymph node positivity reported in 71 studies.
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dissection in colorectal cancer most often with aid of 
clearance techniques (Table 7)[22,23,48,128-137]. Only the 
authors study was restricted to colon cancers. All these 
studies are limited by relatively small case numbers 
ranging from 15 to 188. Nevertheless, nine studies 
report upstaging from N0 to N+ after re-evaluation 
of the specimens in up to 31%. All studies reporting 
relatively high upstaging rates between 5%-31%, 
however, show poor harvest results after the initial 
dissection step with mean numbers between 3 and 
10 lymph nodes. In studies with adequate or high 
primary lymph node counts upstaging occurs almost 
exclusively in single cases. 
Influence of advanced dissection techniques on staging
Eleven studies published between 1999 and 2015 
which compared the result of advanced techniques 
like fat clearing or methylene blue injection with 
conventional manual dissection were selected 
to investigate the influence of these techniques 
on staging (Table 8)[16,138-147]. Only three of these 
studies[141,145,146] report significant higher node 
positivity rates in the study groups compared to the 
control groups. Despite acceptable or even excellent 
lymph node yields the rates of node involvement was 
considerable low in the control groups of these studies. 
The study groups showed results comparable to the 
values achieved by standard technique as shown in 
the section above. This indicates that the reported 
differences might by caused more by the especially 
low metastatic rates in the control arms than by the 
effect of the advanced technique. A study performed 
by the authors group including more than 1300 cases 
revealed no differences regarding the local metastatic 
rate[16]. 
CHANGES OF LYMPH NODE HARVEST 
OVER TIME
Several studies report an improvement concerning the 
lymph node yields over time with increasing mean/
median lymph node numbers per case and increasing 
rates of adequately staged cases. Twelve studies 
were identified investigating the development from 
the 50ies to present[9,15,17,95,119,120,126,148-151]. An increase 
in evaluated lymph nodes per case is shown in all 
these investigations. However, only three report an 
associated increase of the lymph node positivity rate. 
Analyzing data from 750 patients with pT3 colorectal 
cancers from the SEER database Goldstein et al[149] 
found an almost continuous increase concerning the 
mean lymph node count from 3.3 in the 1950ies to 
19.4 in 1990ies. Reaching a mean count of 8.4 lymph 
nodes the metastases rate increased relatively abruptly 
from rates ≤ 35% to 38%-53%. A rate of 70% 
found in the latest investigation period is very likely 
a statistical outlier. In 2002 Goldstein published an 
analysis of an enlarged group from the SEER database 
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Figure 3  Association between the rate of pT3/4 cancers and the lymph node positivity rate in 51 studies (A) and rate of cases with inadequate lymph node 
harvest (< 12 LN) and lymph node positivity (B).
Table 6  Lymph node positivity rates of the five largest studies
First author Year n Register N+ rate Insuff rate Rate T3/4
Gleisner 2013 154208 SEER 34% NA 69.4%
Baxter 2010 110444 SEER 41% 53.6%  100%
Ricciardi 2006 106900 SEER 34%    57%    73%
Gonsalves 2011   19240 VACCR 30% NA 61.1%
Chang 2012     9644 Taiwan Cancer Database 41% 27.7% 80.2%
SEER: Surveillance, Epidemiology and End Results cancer registry; VACCR: Veteran's Affairs Central Cancer Registry; NA: No available data.
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including 2427 pT3 cases[9]. Again, the author found a 
similar association. Noteworthy, despite a temporary 
decrease of the lymph node yield in the 1980ies the 
trend of an increasing rate of lymph node metastases 
was not affected. Wong et al[95] investigated a cohort of 
total 345 patient between 1995 and 1999. They found 
an inverse association between increasing numbers 
of investigated lymph nodes and the percentage of 
node negative cases. However, similar mean lymph 
node numbers in 1995 and 1997 corresponded to 
considerable differing node negative rates of 65% 
and 55.4%, respectively. This indicates that random 
changes could play a major role. All other studies 
including total about 250000 patients found no change 
in the rate of lymph node metastases over time 
although the lymph node yield could be improved 
significantly.
COMPARISON OF DIFFERENTLY 
PERFORMING HOSPITALS
Hospitals belong to the factors that inhere with 
the lymph node harvest in colon cancers. Several 
investigations addressed this issue particular with 
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Table 7  Upstaging rates after re-evaluation






Up-rate Location Technique Comment
Scott 1989 103 6.2    12.4 Yes      8.6% CR Fat clearing 5yFU available
Haboubi 1992   41 6.7    58.2 Yes        28%1 CR Fat clearing Based on HE; 
higher up-staging with ICH1
Cohen 1994   41 13 17 ?1 1 CR Xylene Upstaging in 1 single case; 
primary N-stage (N0/1) not given; 
%tage N+ not given1
Koren 1997   30 2.6      8.6 Yes       31% CR Fat clearing
Brown 2005   15 20.8    89.6 Yes 1 CR ESMT 1 of 7; however unclear wether it was a 
LN metastasis or a deposit1
Kim 2007   48 19.4 43 No / CR ESMT
Richter 2007 188 n.m. n.m. Yes min 4% CR Fat clearing Initinal insuff rate 59; after 9
Vogel 2008   80 6.9    11.3 Yes          2% CR Fat clearing
Märkl 2008   30 17 25 Yes          3% C Fat clearing Primarily conventional technique
Märkl 2008   30 35 40 No / C Fat clearing Primarily methylen technique
Fan 2010 115 9.1    14.2 Yes 5%-10%1 CR Re-evaluation Insuff Rate 79%; Up Staging rate not 
exactly calculatable
Hernanz 2010   50 13.9    23.9 Yes          4%1 CR Fat clearing based on own calculation
Chapman 2012   94 22.5 29 Yes 1 CR Schwartz-clearing 1 single case upstaged1
Chen 2014   83 7.2    14.1 No / CR Re-evaluation: 
partly Fat clearing
Ma 2014   55 9.8    18.4 Yes1 1 CR GEWF Upstaging in cases with primary 
insufficient LNY; 3 cases N0 to N+1
1See comment in the same row. CR: Colorectal; C: Colon; ESMT: Entire submission of mesenteric tissue; GEWF: Glacial acetic acid, ethanol, distilled water, 
formaldehyde; LN: Lymph node.
Table 8  Results of advanced pathological lymph node dissection techniques in colorectal cancers




N+ Konv N+ Spec T3/4 Konv T3/4 Spec Technique P  value
N+ rates
Ratto 1999   801 11.4% 29.4% 30.2% 37.5% 76.9% 84.5% Fixing Technique < 0.05
Newell 2001     67   6.8% 10.2%    31%    46%    81%    85% GEWF NS
Kukreja 2009   701 12.8% 17.3% 36.9% 32.4% 65.8% 62.8% Fat clearance NS
Törnroos 2009     32    22%    61% 56.3% 37.5% 100%  100% MB NS
van Steenbergen 2010   170    11%    14%    42%    41%    80%    79% mesent. Patent Blue 
Injection
ND
Frasson 2012   473 20.6% 37.1%/47.6% 38.9%    48% 80.9%    72% MB NS
Jepsen 2012   428    24%    37%    9.4%1  26.7%1    82%    81% MB 0.040
Märkl 2013 1332    13%    34%    37%    37%    65%    63% MB ND
Kir 2014   180 21.5% 24.5%    28% 47.9% 91.6% 84.9% MB 0.006
Borowski 2014   100    15%    23%       34%1,2       40%1,2 NA NA MB NS
Iversen 2015   120   9.5% 16.5%    44%    36%    81%    71% GEWF NS
1Subgroup of T1/2 cases; 2Based on the number of % Dukes C cases. LN-Conv.: Lymph node harvest of conventional dissected cases; LN–Spec: Lymph 
node harvest of cases using advanced techniques; NA: No data available; GEWF: Glacial acetic acid. ethanol. distilled water. formaldehyde; MB: Methylene 
blue assisted lymph node dissection; NS: Not significant; ND: No difference.
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respect on its impact on the detection of lymph node 
metastases. Nine such studies published between 
2004 and 2014 were identified[68,80,105,109,122,125,129,152,153]. 
Miller et al[152] evaluated the performance of low-, 
medium and high volume hospitals and found 
significant differences concerning the rate of poor 
lymph node harvest (< 7 lymph nodes) and lymph 
node positivity rates of 15.2% vs 35.6% and 42.6%, 
respectively between the low volume hospitals and the 
other hospital categories. Chen et al[129] analyzed two 
branches of the same institution and found significant 
differences with rates of inadequate staging in 20% 
vs 75% with corresponding lymph node positivity 
rates of 40.5% vs 30.6%. This was also associated 
with an increased long term survival. In contrast, all 
other seven studies, did not identify an association 
between the number of identified lymph nodes and 
the rate of stage Ⅲ cancers on the hospital level. 
Despite the lacking impact on staging, an influence of 
lymph node count on survival could be shown. Wong 
et al[68] showed a favorable outcome for cases with 
≥ 12 evaluated lymph nodes on the patients’ level. 
Survival difference for N0 patients between differently 
performing hospital despite similar rates of lymph node 
positivity were reported by Wong et al[105].
INDICATIONS FOR THE ROLE OF 
IMMUNE RESPONSE
Facing limitations of the current explanation of the 
prognostic impact of lymph node count a possible 
link between immune response and the number of 
detected lymph nodes was proposed by a number 
of authors discussing their results or commenting 
other’s papers[19,42,68,102,150,154]. These authors suggest 
changes of the lymph nodes - either enlargement 
or a diminishing - that alter its detectability. The 
associated differences in the number of identified 
number of lymph node would display a surrogate 
marker of the immune response against the tumor. 
The important role of the immune system for the 
patient’s prognosis is unquestionably. For instance 
tumor infiltrating lymphocytes are associated with a 
favorable prognosis[155]. The same is true for crohn-
like reactions in colon cancer[156].
To the authors knowledge, however, there are 
only a few studies published that investigated a direct 
connection between parameters representing the 
extent of an immune response and the numbers of 
investigated lymph nodes. Recently, Kim et al[18] as 
well as George et al[102] found an association between 
tumor infiltration lymphocytes and the number of 
retrieved lymph nodes. In 1980 Pihl et al[157] described 
favorable outcomes in colorectal cancer cases with 
germinal center- or paracortical hyperplasia in Dukes B 
and C stages. Dworak[158] reported 1991 the incidence 
of germinal center- and paracortical hyperplasia in 
non-involved lymph nodes in rectal cancers. The 
author, however, did not perform a survival analysis. 
An association between the occurrence of ≥ 7 lymph 
nodes larger than 5 mm with the total number of 
dissected lymph node and with favorable outcome was 
shown by the authors group[62]. As mentioned above 
microsatellite instability is found to be associated 
with lymph node harvest by a several authors[14,53,64]. 
Moreover, it is a well-known predictor for a favorable 
prognosis and immunologic factors are believed to be 
the reason for that[159]. 
CONCLUSION
Lymph node harvest has a substantial impact on the 
prognosis in colon cancer and has been proven in 
many investigations as could be shown in this review 
and also in a systematic review by Chang et al[7].
The number of harvested lymph nodes in colon 
cancers is influenced by a number of modifiable and 
unmodifiable factors. The pathologist, surgeon and 
the hospital volume belong to the modifiable factors. 
Age, tumor stage, location and genetic alterations of 
the tumor are unchangeable. Stage migration also 
known as Will-Rogers-phenomenon is believed to be 
the result of understaging of stage Ⅰ/Ⅱ cases caused 
by poor lymph node retrieval. If this is true surgeons 
and/or pathologist would be to blame for it. 
Depending on the used technique and the extent 
of the operation surgeons doubtless can influence 
the number of identifiable lymph nodes in colonic 
specimens. Therefore, it is to assume that more 
restricted excisions are prone to miss involved lymph 
nodes. To the author’s knowledge, however, there is no 
evidence for that. On the other hand there are some 
arguments at least against a relevant frequency of its 
occurrence. Complete mesocolic excision has shown 
to be associated with reduced local recurrence and 
superior overall and disease-free survival in stage Ⅱ 
and Ⅲ cancers[160,161]. Nevertheless, despite improved 
lymph node yields the rates of nodal positive cases 
did not increase by this technique and seem therefore 
unrelated to the improved outcome results. Moreover, 
the reported rates of local recurrence after curatively 
intended resections are low which seem not compatible 
with a relevant rate of missed positive lymph during 
surgical excision[162]. Law et al[81] reported a higher 
incidence of recurrence in stage Ⅱ colon cancers with 
inadequate lymph node harvest. Interestingly, this was 
caused by a higher rate of distant metastases. The 
rates of local recurrence did not differ between well 
and poorly lymph node harvested cases.
On the other hand it seems obvious that path-
ologist in deed have a big influence on the number of 
reported lymph nodes. This can be stated based on 
the author’s experience in daily practice and many 
reports in the literature. The fact that pathology 
assistants and young residents do a better job than 
pathologist by spending more time and diligence[35,37] 
as well as the fact that the same surgeons achieve 
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different results when he is collaborating with different 
pathology department[67] are only two examples. If 
pathologist missed positive lymph nodes by inadequate 
dissection of the specimens in a significant number 
differences regarding the lymph node positivity rates 
should be determinable. However, the analysis of the 
data provided in the literature shows no association 
between the rate of inadequate lymph node yields 
and the rate of lymph node positivity (Figure 2). 
Upstaging occurs after reevaluation, however, this 
is mainly restricted to cases with poor lymph node 
harvests or single cases as shown above. Techniques 
to improve lymph node harvest are highly effective but 
not associated with higher rates of stage Ⅲ cancers[38]. 
This is remarkable. However, pathologists seem to be 
highly effective in picking the relevant lymph nodes 
from the correct area. In an experimental model the 
authors group could show that there is 63% chance 
to detect the first lymph node metastases within the 
first five dissected lymph node. This increases to 86% 
when analyzing the first nine lymph nodes[163]. The 
work of Mainprize et al[164] point in the same direction.
These arguments raise doubts that understaging 
is actually a relevant problem in the management of 
colon cancer. The comparison of differently performing 
hospitals as well as the analysis of the continuously 
improved lymph node harvest results over time show 
in the vast majority of studies no association between 
the numbers of investigated lymph nodes and the rate 
of lymph node positivity. 
Another point is that lymph node count was shown 
to be prognostic in stage Ⅲ cancers at least in a part 
of studies. Stage migration in these cases is ruled out, 
naturally. Based on these arguments stage migration 
as reason for the well investigated prognostic impact 
can be excluded in the author’s point of view. If at all 
stage migration effects seem to be restricted to the 
very poorly staged node negative cases. Such cases 
show a prognosis similar to stage Ⅲ cancers. If false 
negative diagnoses would be the reason for that 
logically 100% of these cases actually had to be node 
positive, which seems very unlikely.
In concordance with other authors[19,42,68,102,150,154] 
one can state that a confounder which is related to the 
both lymph node harvest and to outcome has to be 
searched. It seems very likely that immune response 
is this confounder. A strong reaction can cause 
lymphatic hyperplasia with enlargement of lymph 
nodes and enhanced detectability. On the other hand 
an intensive immune reaction can prevent the patient 
from tumor progression. This hypothesis, however, 
is not proven yet. Nevertheless, there are indications 
pointing in this direction. Emerging evidence is 
provided by studies addressing the impact of lymph 
node reactions on survival as well as the prognostic 
relevance of lymph node size and tumor infiltrating 
lymphocytes[16,18,102,157,158]. Microsatellite instable 
tumors seem to be especially immunogenic associated 
with both high lymph node counts and reduce risk of 
progression. They could, therefore, serve as model 
helping to understand what happens.
This is of high clinical relevance. The role of lymph 
node number as reliable quality marker becomes 
more and more questionable. More important a 
low lymph node count is currently accepted as a 
risk factor and often prompts the administration of 
adjuvant chemotherapy[165]. In many cases such poor 
lymph node harvests are probably not the result of 
poorly performing physicians but the expression of 
an impaired immune response. With growing success 
of quality initiatives these cases will escape from a 
possibly necessary adjuvant therapy by forcing the 12 
lymph nodes. It is therefore of crucial importance to 
close the existing knowledge gaps and reconsider the 
concerned recommendations.
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